Web-based Survey on the Occurrence of Emotional Blunting and Treatment Needs in Japanese Patients with Major Depressive Disorder

Web-based Survey on the Occurrence of Emotional Blunting and Treatment Needs in Japanese Patients with Major Depressive Disorder - Web-based Survey on Emotional Blunting in Japanese Patients with Major Depressive Disorder

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000048497

Enrollment

3000

Registered

2022-07-28

Start date

2022-07-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The following subjects are eligible for the survey if they meet all of the following criteria: (1) Aged between 18 and 59 years old (regardless of gender) (2)Those who have been diagnosed with MDD. (3)Those who have been taking antidepressant medication for at least three months. (4)Those who have been visiting a hospital for more than three months. (5)Those who can use the Internet with a personal computer, smartphone, or tablet. (6)Those who can give consent online based on their own free will after understanding the explanation in Japanese.

Exclusion criteria

Exclusion criteria: The preliminary web-based questionnaire ask whether any of the following conditions are met, and those who meet the conditions are not eligible for the survey. (1) Those who have been diagnosed with bipolar disorder. (2) Those who have been diagnosed and are under treatment for serious progressive physical illnesses such as cancer and heart failure.

Design outcomes

Primary

Measure	Time frame
Occurrence ratio of Emotional Blunting (EB) in Japanese patients with major depressive disorder	—

Secondary

Measure	Time frame
1. The scores of Oxford Depression Questionnaire (ODQ) 2. Correlation between severity of EB (ODQ) and severity of depressive symptoms (PHQ-9: Patient Health Questionnaire-9), or anxiety symptoms (GAD-7: Generalized Anxiety Disorder-7), social functioning (WSAS: Work and Social Adjustment Scale), QOL (EQ-5D-5L) 3. Patient's perception for EB 4. Treatment need for EB	—

Countries

Japan

Contacts

Public ContactTomoki Ohashi

Macromill Carenet, Inc. Macromill Carenet, Inc.

to_ohhashi@macromillcarenet.jp070-1399-0192

Outcome results